Logo image of PBM

PSYENCE BIOMEDICAL LTD (PBM) Stock Overview

USA - NASDAQ:PBM - CA74449F3088 - Common Stock

3.44 USD
+0.02 (+0.58%)
Last: 10/21/2025, 5:48:49 PM
3.49 USD
+0.05 (+1.45%)
After Hours: 10/21/2025, 5:48:49 PM

PBM Key Statistics, Chart & Performance

Key Statistics
Market Cap2.44M
Revenue(TTM)N/A
Net Income(TTM)N/A
Shares710.00K
Float710.00K
52 Week High63.36
52 Week Low2.36
Yearly DividendN/A
Dividend YieldN/A
EPS(TTM)N/A
PEN/A
Fwd PEN/A
Earnings (Next)N/A N/A
IPO2021-12-10
Sector
GICS SectorHealth Care
GICS IndustryBiotechnology
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS SubIndustryBiotechnology


PBM short term performance overview.The bars show the price performance of PBM in the last week, last 2 weeks, last month, last 3 and 6 months. 1 week 2 week 1 month 3 months 6 months 0 -20 -40 -60

PBM long term performance overview.The bars show the price performance of PBM in the last 1, 2 and 3 years. 1 year 2 years 3 years -20 -40 -60 -80

The current stock price of PBM is 3.44 USD. In the past month the price decreased by -5.82%. In the past year, price decreased by -94.12%.

PSYENCE BIOMEDICAL LTD / PBM Daily stock chart

PBM Latest News, Press Relases and Analysis

PBM Competitors/Peers

The largest stocks on the US markets in the "Biotechnology" sub-industry
Full List
Symbol
Company Name
TA
FA
PE
Market Cap
ABBV ABBVIE INC 21.85 408.76B
AMGN AMGEN INC 13.81 162.12B
GILD GILEAD SCIENCES INC 16.03 153.96B
VRTX VERTEX PHARMACEUTICALS INC 25.16 109.29B
ALNY ALNYLAM PHARMACEUTICALS INC N/A 62.13B
REGN REGENERON PHARMACEUTICALS 12.69 61.40B
ARGX ARGENX SE - ADR 90.64 51.39B
INSM INSMED INC N/A 34.94B
ONC BEONE MEDICINES LTD-ADR 5.1 34.68B
BNTX BIONTECH SE-ADR N/A 25.70B
NTRA NATERA INC N/A 25.65B
BIIB BIOGEN INC 9.13 21.44B

About PBM

Company Profile

PBM logo image Psyence Biomedical Ltd. is a holding company, which engages in the development and commercialization of pharmaceutical products in neurology. The company is headquartered in Toronto, Ontario and currently employs 12 full-time employees. The company went IPO on 2021-12-10. The firm is focused on developing nature-derived (non-synthetic) psilocybin-based psychedelic medicine. The company is dedicated to addressing unmet mental health needs, particularly in palliative care. Its ongoing Phase IIb psilocybin clinical trial in Australia focuses on adjustment disorder in patients diagnosed with cancer.

Company Info

PSYENCE BIOMEDICAL LTD

121 Richmond Street West Penthouse, Suite 1300

TORONTO ONTARIO V6E 3Z3 CA

CEO: John Plourde

Employees: 12

PBM Company Website

PBM Investor Relations

Phone: 17744604171

PSYENCE BIOMEDICAL LTD / PBM FAQ

What is the stock price of PSYENCE BIOMEDICAL LTD today?

The current stock price of PBM is 3.44 USD. The price increased by 0.58% in the last trading session.


What is the ticker symbol for PSYENCE BIOMEDICAL LTD stock?

The exchange symbol of PSYENCE BIOMEDICAL LTD is PBM and it is listed on the Nasdaq exchange.


On which exchange is PBM stock listed?

PBM stock is listed on the Nasdaq exchange.


What is PSYENCE BIOMEDICAL LTD worth?

PSYENCE BIOMEDICAL LTD (PBM) has a market capitalization of 2.44M USD. This makes PBM a Nano Cap stock.


How many employees does PSYENCE BIOMEDICAL LTD have?

PSYENCE BIOMEDICAL LTD (PBM) currently has 12 employees.


What are the support and resistance levels for PSYENCE BIOMEDICAL LTD (PBM) stock?

PSYENCE BIOMEDICAL LTD (PBM) has a support level at 3.42 and a resistance level at 3.84. Check the full technical report for a detailed analysis of PBM support and resistance levels.


Should I buy PSYENCE BIOMEDICAL LTD (PBM) stock?

There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:


Does PSYENCE BIOMEDICAL LTD (PBM) stock pay dividends?

PBM does not pay a dividend.


What is the Short Interest ratio of PSYENCE BIOMEDICAL LTD (PBM) stock?

The outstanding short interest for PSYENCE BIOMEDICAL LTD (PBM) is 5.39% of its float. Check the ownership tab for more information on the PBM short interest.


PBM Technical Analysis


Chartmill TA Rating
Chartmill Setup Rating

PBM Financial Highlights


Industry RankSector Rank
PM (TTM) N/A
ROA N/A
ROE N/A
Debt/Equity N/A
Chartmill High Growth Momentum
EPS Q2Q%N/A
Sales Q2Q%N/A
EPS 1Y (TTM)N/A
Revenue 1Y (TTM)N/A

PBM Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next YN/A
Revenue Next YearN/A

PBM Ownership

Ownership
Inst Owners44.69%
Ins OwnersN/A
Short Float %5.39%
Short Ratio0.01